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Abstract
Whereas the usual way to gain access to the vascular bed for hemodialysis is by inserting two needles, an alternative option 
based on the introduction of only one needle has been available for several decades. Although single needle hemodialysis 
gradually lost popularity in the early nineties of last century, this option now seems to make a come-back, with the current 
change in patient mix towards more elderly and cardio-vascular disease and the appearance of more flexible hardware. Sin-
gle needle hemodialysis offers several advantages, such as the possibility to puncture small or maturing access systems, a 
decrease in number of punctures with less potential access damage and subsequent complications, the avoidance of central 
vein catheter use, and an improved quality of life by reducing puncture-related pain, stress and complications. The main 
drawback is recirculation which however can be overcome (if considered necessary) by making dialysis somewhat longer 
and in addition has more impact on removal of small water soluble compounds than on clearance of the more toxic difficult 
to remove solutes (middle molecules and protein bound compounds). Effective dialyzer blood flow with single needle dialy-
sis cannot be much higher than 300 mL/min, which however also offers advantages by making short dialysis sessions less 
feasible and thus reducing the likelihood of intradialytic blood pressure falls, organ stunning and other negative outcomes 
of shorter dialysis. Direct outcome comparisons between single and double needle dialysis are not available but indirect 
data suggest no differences, in as far as efficient enough access perfusion can keep dialyzer blood flow adequate. The single 
needle method seems especially suited for the elderly and for home hemodialysis. Recent technological improvements have 
made the system more accessible and adequate, but further studies are needed to assess with modern methodologies the 
clearance kinetics of these systems, which could emanate in further technological fine-tuning.
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Introduction
The advent of arterio-venous grafts and fistulae enabled 
repeated access to the vascular bed for maintenance hemo-
dialysis, precluding a fatal end of chronic end-stage kidney 
disease. The traditional approach is by inserting two nee-
dles, allowing blood purification by continuous blood flow 
through the dialyzer. However, from those early days on, 
some clinicians also considered using only one needle.
In the double needle approach, blood saturated with ure-
mic toxins is extracted via one needle, transferred to the 
dialyzer, brought into contact with dialysate and/or filtered 
through a semi-permeable membrane, and after purification 
returned via a second needle, which, if possible, is inserted 
at some distance of the first needle. In contrast, in single nee-
dle dialysis, blood entering and leaving the system follows 
a common pathway. During the early inflow phase, purified 
blood that filled the needle during outflow, is reentering the 
system to be purified once more, hence decreasing the poten-
tial for mass transfer and thus removal (recirculation—see 
below).
In this publication we will review the history and the 
advantages and limitations of single needle dialysis. It is 
acknowledged that direct evidence in favor of the single nee-
dle strategy is often missing, so that a number of viewpoints 
in this publication are extrapolated from indirect evidence. 
Hopefully, this text will stimulate the nephrological commu-
nity to study modern day single needle dialysis more inten-
sively with the intention to provide a more solid evidence 
base and further fine tuning this methodology.
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History
The father of modern hemodialysis, Willem Kolff, was 
one of the first to develop a single needle system [1]. 
These early systems were however entirely time con-
trolled, resulting in a too fast alternation between inflow 
and outflow, high recirculation and a lack of adequacy. 
Somewhat later, partially or entirely pressure regulated 
systems (pressure–time or pressure–pressure) were devel-
oped which allowed a better control of cycle alternation 
and thus more adequate dialysis [2].
Although single needle dialysis reached a certain level 
of popularity, especially in Europe, it largely lost its posi-
tion in the early eighties of previous century. However, 
in view of recent innovations [3], the concept might be 
ready for a revival. In this review we will summarize the 
advantages, limitations, indications and contraindications 
of single needle dialysis, with attention to both the older 
and more recent literature.
Single needle dialysis can be performed via one lumen 
(single lumen single needle) or with two lumens (double 
lumen single needle), whereby inflow and outflow tract 
are divided by a central septum separating two semicircu-
lar lumens or are positioned coaxially with an inner and 
an outer circular lumen. Such systems minimize the effect 
of recirculation (without entirely eliminating it as inflow 
and outflow remain close), but this decrease in recircula-
tion is offset by blood flow limitations and an increase 
in shear stress. In addition, needles are thicker than with 
single lumen, necessitating too much pressure on the skin 
for perforation [2], enhancing insertion pain and patient 
discomfort. Also excessive bleeding upon their removal 
has been reported [2].
In this publication, we will only discuss single lumen 
single needle dialysis.
Advantages (Table 1)
Needling of small fistulas
Single needle dialysis allows needling of small access sys-
tems. Even if in well constructed fistulae flow increases 
quickly after their creation [4], access problems are frequent 
in the first 3 months [5, 6]. It may take some time until a 
segment becomes long enough for double puncture [7], and 
single needle dialysis allows earlier puncture of maturing 
fistulae [8, 9].
Likewise, if fistulas remain small because of vascular dis-
ease, old age, obesity, or the presence of tortuous veins [10] 
or if for these reasons an upper arm (brachiocephalic) fistula 
is installed [11], insertion problems are frequent [7], which 
can be obviated by a single needle approach. The signifi-
cance of these difficulties is rising in view of the increasing 
prevalence of old age and cardio-vascular risk factors among 
today’s dialysis population [12, 13]. Single needle dialysis 
is however no solution for fistulas without adequate blood 
flow [2] (see below).
Decreasing the number of fistula punctures
Fistula loss is one of the main factors defining negative 
outcome of hemodialysis patients [14–16]. Access patency 
is lost progressively as time since the initiation of dialysis 
progresses [17] (and the cumulative number of punctures 
increases). One of the main reasons for fistula failure is their 
frequent laceration by needling, resulting in stenosis, throm-
bosis and inadequate flow. Single needle dialysis reduces 
the number of access punctures by 50%, and concomitantly 
also decreases the damage to fistula cell layers and the risk 
of complicated and multiple cannulation procedures [18], 
which cause pain and stress next to endangering the access 
system itself [18, 19] (see below).
Table 1  Advantages of single needle dialysis
Characteristics Remarks
Enables the puncture of small fistulae Adequate dialysis only possible with sufficient access blood flow
Enables the puncture of maturing fistulae Adequate dialysis only possible with sufficient access blood flow
Decreases the number of fistula punctures
Decreases fistula damage and its consequences (thrombosis, stenosis, inad-
equate flow)
Decreases the risk of complicated needling procedures (hematoma, infiltra-
tion)
Avoids central vein catheter use Avoids negative outcomes linked to central vein catheter dialysis
Improves quality of life
Decreases pain and stress
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Unfortunately, there are no direct comparative fistula sur-
vival data between single needle and double needle dialysis, 
so that we can only rely on indirect arguments.
The daily trial of the Frequent Hemodialysis Network 
(FHN), primarily compares mortality and left ventricular 
hypertrophy in standard thrice weekly vs. six times weekly 
hemodialysis, but one of the secondary analyses assesses 
the number of access interventions [20]. Although the study 
was not powered for access problems, a trend for more fis-
tula interventions was observed in the frequent dialysis arm, 
which by definition implies a double number of access punc-
tures vs. standard, in the same way as double needle vis-à-
vis single needle dialysis.
In the dialysis unit of the University Hospital Ghent, all 
patients without exception were treated with single needle 
dialysis until the early nineties of last century. In 1987, the 
experience in this unit was compared to data in other stud-
ies on double needle dialysis (hereafter referred to as the 
Ghent single needle dialysis study) [21], and also contained 
an assessment of vascular access outcomes compared to 
contemporaneous studies in double needle dialysis which 
revealed substantially higher 5-year patency for single nee-
dle dialysis [21, 22].
In the probably most direct comparison, fistula compli-
cations as illustrated by the need for central vein catheter 
insertion, investigative access procedures (e.g. fistulagraphy) 
and missed dialysis sessions, were less frequent with single 
needle than with double needle dialysis [23].
Avoidance of central vein catheters
When access patency is lost, the only option to continue 
hemodialysis is via the placement of a central vein catheter. 
Although this type of analyses does not exclude residual 
confounding, many observational studies point to an associa-
tion of catheter dialysis with a negative prognosis as com-
pared to fistula or graft dialysis [14, 15, 24, 25]. In addition, 
in a group of hemodialysis patients who were all treated by 
central vein catheters at the beginning of a 6 month observa-
tion period, C reactive protein (CRP), a surrogate outcome 
marker of which an increase of concentration is associated 
with mortality and cardiovascular events even when in the 
normal range [26, 27], was high normal [28]. Whereas CRP 
decreased dramatically in the patients who were switched 
to a fistula during follow-up, in the subgroup remaining on 
a catheter CRP even increased slightly, with a significant 
difference between both study arms at the end of follow-up 
[28]. Of note, reportedly, none of the catheters in that study 
was infected during the study course.
In view of this negative outcome potential of central vein 
lines, single needle dialysis offers several benefits. Not only is 
it of help to preserve fistula integrity thus allowing safe gard-
ing in a preventive way patency and thus avoiding a future 
need for catheter use when patency would be lost [23] (see 
above), in addition it may help avoiding catheters during the 
early maturation process. Moreover, an observational analy-
sis in the context of the Dialysis Outcomes Practice Patterns 
Study (DOPPS) showed an association between central vein 
catheter use in the period before first fistula puncture and 
maturation disturbances [16]. In the recent European Best 
Practice Guidelines on vascular access, early fistula puncture 
(after week 2 but before week 4) is suggested as preference if it 
can help obviating catheter dialysis, and single needle dialysis 
is proposed as one of the options to make this possible [8, 9].
Improving quality of life
The interest of the nephrological community in patient-cen-
tered outcomes and patient empowerment is growing [29]. 
Quality of life worries related to vascular access mainly are 
centered on the pain induced by access puncture and fear for 
painful or disabling complications [30]. Yet, patient-related 
outcomes were and still are a neglected aspect in clinical 
hemodialysis access research [31].
Single needle dialysis reduces the number of access punc-
tures by half. Moreover, its impact via reducing punctur-
ing mistakes is likely even more important, as the second 
puncture usually is more problematic than the first one, 
especially in small or not yet matured access systems. In 
addition, the complications generated by these erroneous 
punctures such as hematoma, infiltration, or thrombosis, 
as well as the catheter insertion to provide an alternative 
access and the angioplastic or surgical interventions to cor-
rect them or to create a new access system are a source of 
even more pain and worries. One of the most appreciated 
vascular access outcomes by hemodialysis patients is a long 
period without access intervention [30]. Pain reduction is 
an important bonus point for single needle dialysis. Pain at 
access puncture is a patient-centered outcome that rarely has 
been studied. Although access related pain has been identi-
fied as highly relevant to patients [32, 33], yet this outcome 
was studied in only 11% of vascular access trials [31]. In an 
international survey by Standardized Outcomes in Nephrol-
ogy (SONG), pain was classified by patients and caregivers 
as the most frequent access related complication, together 
with cannulation problems [34] (both 40%). A patient prefer-
ence for single needle dialysis, because of more comfort and 
less punctures, has been reported [35].
Limitations (Table 2)
Blood flow
As the direction of blood movement through the access 
needle is alternated at every cycle, maximum inflow/
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outflow for each rotation is about two times higher than 
the effective flow in the dialyzer. If this maximum flow 
exceeds or even approaches access flow, this will result in 
excess recirculation [36], system collapse, interruptions of 
dialysis due to alarms and/or shear stress related compli-
cations (hemolysis, thrombogenicity, dialyzer pore clog-
ging). An effective (mean) flow of ± 300 mL/min is to the 
best of our knowledge the maximum that has been reached. 
When in the Ghent single needle dialysis study, effective 
inlet (arterial) blood flow was measured real time by the 
bubble method (measuring the volume of displaced blood 
per time unit from the distance travelled by an air bubble 
through a long tubing with known dimensions), a value 
of 284 ± 33 mL/min (n = 76) was found [21]. Of note, this 
parameter refers to real flow, not peak flow, as the bubble 
is followed over several pump cycles, progressing each 
time the pump on its side is rotating, to stop when the 
alternative pump is activated. In other publications, blood 
flow rates ranging from 269 to 286 mL/min have been 
reported [37]. These were mostly obtained with a pres-
sure–pressure regulated system with one motor and two 
pump heads that was manually calibrated to an optimal 
stroke volume of about 40 mL per cycle [21]. However, 
more recent (and more sophisticated) systems seem to 
reach somewhat lower average blood flows (180–220 mL/
min) [3], although this lower value is in some systems 
compensated by other characteristics that positively affect 
adequacy (see below).
Single needle dialysis is thus hard to match with 
very high blood flows. However, the seminal question is 
whether those high flows are really needed, especially in 
older patients, who are one of the targeted populations of 
single needle systems (see below). High blood flows are 
usually coupled to shorter dialysis sessions, increasing the 
risk of intradialytic hypotension [38–40] and of vital organ 
stunning [41, 42], while effective removal is decreased 
compared to low flow, low efficiency dialysis [43].
In addition, single needle dialysis is no solution for 
fistulas without adequate blood flow [2], in which case 
treatment will be inadequate irrespective of the needling 
system. The problem will be even worse with the single 
needle option since its high peak flows increase recircula-
tion in case of inadequate access [36].
Table 2  Limitations of single needle dialysis
a Arguments in italics are positive elements partially or entirely counterbalancing the limitations
Characteristics Remarks
Effective dialyzer blood flow cannot be much 
higher than 300 mL/min and is often lower
Makes short dialysis sessions difficult
Longer dialysis sessions improve solute removal and are less prone to hypotension and stunninga
Recirculation Decreases mass transfer and clearance
May occur to a certain extent also in double needle dialysis
Relative impact of recirculation on clearance is only a fraction of its percent value
Can if needed be compensated by increasing dialysis length
Recirculation mainly impacts removal of small water soluble solutes but much less that of “dif-
ficult to remove solutes” (middle molecules or protein bound solutes)
Impact is most important for short dialyses at high efficiency but less on slow low flow extended 
dialysis (SLED)
Difficulty to reach recommended Kt/V values Can be compensated by increasing dialysis length
Acceptable values have been reported, especially with the more recent systems
Frequent alarms Can be overcome with appropriate hardware
Possibly related to dialysis via inadequate access systems
May be limited by experienced personnel
Hemolysis Mainly with older systems
Partly linked to factors not related to single needle as such (e.g. incorrect tubing insertion in 
roller pumps)
Blood flow in the dialyzer is irregular Can be overcome with appropriate hardware and system design
Backfiltration Can be avoided by appropriate hardware
Is no problem with ultrapure dialysate
May increase dialysis adequacy
Hemodiafiltration not possible Essentially a problem with the current dialysis machines
Hemodiafiltration may have less added value for the target population of single needle dialysis
High venous return pressure Potentially damaging to the vascular access wall
Not corroborated by (indirect) literature data
Outcomes are less beneficial Reasoning in part based on negative experience with use with inadequate access
Not corroborated by (indirect) data
Direct comparison with two needle dialysis is missing
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Recirculation
In view of the common pathway for inflow and outflow 
blood, recirculation and the ensuing decrease in mass trans-
fer and clearance are unavoidable drawbacks.
The degree of recirculation is lower for double pump 
systems as compared to the older single pump systems [2]. 
In addition, also the number of cycles per time unit has a 
substantial impact: recirculation diminishes as the time 
taken by one cycle becomes longer [44]. With the older 
pressure–pressure regulated systems, the number of alter-
nating inflow and outflow cycles was manually calibrated 
by dialysis personnel. The optimum number was defined as 
7–8/min, which combined with a stroke volume of 40 mL 
resulted in the blood flow of approximately 280 mL/min 
mentioned above [2]. With appropriate modern software, 
similar values could presumably be obtained by mimicking 
electronically the empirical reasoning held previously by 
the dialysis nurse.
Percent recirculation values with pressure–pressure 
systems range between 9 and 15% for fistula needles and 
14–25% for central vein catheters [2, 21, 45, 46].
However, even double needle dialysis is not free of recir-
culation, especially if the position of the two needles is close 
to each other, access flow is not high enough for the flow in 
the dialysis system or in the presence of downstream access 
outflow stenosis.
The relative impact of recirculation on clearance is only a 
fraction of percent recirculation, with a maximum decrease 
of clearance that should always be lower than the percent 
value of recirculation per se (Table 3), unless the unlikely 
possibility would occur that clearance would equal dialyzer 
blood flow. The clearance decline by recirculation can easily 
be overcome, if needed, by prolonging dialysis (Table 3).
Recirculation has the most important impact on small and 
easy to remove molecules like urea, because their clearance 
is high, so that returned blood for outflow is almost devoid 
of those solutes, resulting in a maximal negative effect on 
mass transfer (Table 3A). The loss of removal becomes less 
important as percentage removal over the dialyzer is less 
pronounced (Table 3B), with as hypothetical lowest extreme 
a removal of 0%, whereby the impact of recirculation by 
definition will also be 0.
This implies that recirculation has less impact on clear-
ance of molecules that are difficult to remove by dialysis 
(Fig. 1), such as the middle molecules and protein bound 
solutes, or small water soluble compounds with complex 
kinetics (Table 3B). In a recent in depth review these sol-
utes composed the majority of uremic solutes with strongly 
evidenced toxicity [47] (Table 4). Unfortunately, there are 
not many data corroborating the thesis that single needle 
dialysis has a low impact on removal of middle molecules 
as most studies on toxin removal with single needle dialysis 
go back to an era when only urea and creatinine removal 
were analysed. However a cross-over study by Rostoker 
et al. in patients with adequate fistulae assessed predialysis 
concentration of β2-microglobulin, a middle molecule, and 
phosphate, a cardio-vascular and bone toxin with complex 
kinetics [48, 49], after 1 week of single needle vs. double 
needle dialysis [50]. No differences for β2-microglobulin and 
phosphate between both needling approaches were found, in 
contrast with urea and creatinine removal and dialyzer ionic 
dialysance that were lower with single needle dialysis [50]. 
Nevertheless, one should be careful in comparing predialysis 
concentrations to clearances and in analyzing an impact on 
solute concentration already 1 week after system shift, hence 
this issue needs further study.
In parallel with the impact on molecules with low dialysis 
clearance, recirculation also can be hypothesized to have less 
influence in dialysis strategies with low clearance such as 
low flow extended hemodialysis (Fig. 1). Also this hypoth-
esis is not corroborated by data, though.
Kt/V and clearance
Dialyzer urea clearance (K) multiplied by dialysis time (t) 
and divided by urea distribution volume (V) or Kt/Vurea, 
hereafter named Kt/V, is a universally used but debated indi-
cator of dialysis adequacy [51–55]. Urea dialyzer clearance 
being one of its main determinants, Kt/V is strongly depend-
ent on dialyzer blood flow and prone to be decreased by 
recirculation. Hence, the question arises whether appropri-
ate Kt/V values can be obtained with single needle dialysis.
Table 3  Impact of recirculation on dialyzer clearance
% decrease of clearance was calculated as described in [2] by the for-
mula [1 − KR/K].100 whereby K is dialyzer clearance and  KR a cor-
rection factor that is calculated as K(1 − R)/[1−R(1 − K/QB)] whereby 
R is percent recirculation (as a fraction of 1) and  QB dialyzer blood 
flow. Increase in dialysis length was calculated as 240[(1 − DC] where 
DC is the % decrease in clearance (as a fraction of 1)
a For 240 min of dialysis to compensate loss of clearance
Recirculation (%) Decrease clearance 
(%)
Increase dialysis 
length (min)a
(A) Easy to remove solute (K/QB = 0.7)
 5 3.6 8.9
 7.5 5.4 13.6
 10 7.2 18.7
 15 11.0 29.7
(B) Difficult to remove solute (K/QB = 0.3)
 5 1.6 3.8
 7.5 2.4 5.8
 10 3.2 8.0
 15 5.0 12.7
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Calculation of Kt/V in the Ghent single needle study 
showed a value of 0.98 (single pool) [21, 35] conform with 
the threshold that was applicable at that time [56] but lower 
than the standards proposed nowadays [57]. Apart from 
the discussion whether Kt/V is a valid parameter of dialy-
sis adequacy [54], those relatively low values compared to 
today’s standards should be seen in the context of the dialy-
sis principles applicable at that time, with relatively short 
dialysis sessions and small surface area dialyzers contain-
ing less efficient membranes than today. In the Ghent single 
needle study, average dialyzer surface was only 1.17 m2 for 
a dialysis length of 3 h and 48 min [21].
In a study comparing double needle dialysis at a blood 
flow of 250–300 mL/min to two single needle settings (one 
at effective blood flow of 180 mL/min, and one at 250 mL/
min), Kt/V was lower for both single needle approaches 
(− 33% and − 19% for the respective blood flow strata) 
[50]. In another study, where mean effective blood flow was 
273 mL/min, Kt/V did not differ (1.30 double needle vs. 
1.29–1.34 for single needle) [58]. In a cross-over study, a 
small decrease in weekly Kt/V when switching 4 h double 
needle dialysis to single needle for the same time length, 
was turned around into an increase by prolonging dialysis 
by 30 min (from 1.69 to 1.94) [59]. In another study from 
the same group, there were no differences in Kt/V irrespec-
tive of the needling approach or dialysis length, if thrice 
weekly dialysis was applied [60]. Finally, in a study with a 
novel single needle system equilibrated Kt/V (eKt/V) was 
1.26 ± 0.29 (see below) [3].
Hence, Kt/V values with single needle dialysis are in gen-
eral satisfactory, especially with the more recent hardware, 
or decreases can easily be overcome by minor increases in 
dialysis length, if desired.
Alarms
Single needle systems are often considered to be difficult to 
handle because of frequent alarms. This problem can partly 
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Fig. 1  Effect of double (DN) vs. single needle dialysis (SN) on sol-
ute removal. An extreme example with very high (50%) recirculation 
is shown to highlight differences. Concentration (vertical axis of left 
panels) and removal (vertical axis of right panels) arbitrarily set at a 
maximum of 100 (unspecified) units. Upper parts a, b easy to remove 
molecules. a If inlet concentration (black column) would be at 100 
units and dialyzer removal at 80%, outlet concentration (white bar) 
with double needle (DN) dialysis would be 20. In single needle dialy-
sis (SN) the mixture of both would result in an inlet concentration of 
60 (average of 100 + 20). With 80% removal this would give an outlet 
concentration of 12 units. b (Absolute decrease in concentration—
hatched bars): this would be 80 (100–20) units with double needle 
and 48 (60–12) units with single needle. Thus the loss of removal 
would be by − 40%. Lower parts c, d difficult to remove molecules. 
c Here removal would be only 20 (100–80) with double needle dialy-
sis and 18 (90–72) with single needle. d Absolute removal only shifts 
from 20 to 18, thus here the difference is only − 10%. As in reality 
recirculation will be less than 50%, the changes will be less extreme 
but the proportional differences between easy and difficult to remove 
molecules will remain the same
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be related to the use of this strategy with inadequate access 
systems and partly to limitations in the possibilities for the 
personnel to acquire sufficient expertise because these sys-
tems are often used only sporadically. Modern software may 
enable to overcome such problems [3].
Hemolysis
Hemolysis with single needle dialysis has essentially been 
reported in older studies and is attributed to the peak blood 
flow rates inducing shear stress in the needles, but also to 
incorrect adjustment of the tubings in the blood pumps, 
which is not specific for single needle dialysis [2, 61]. The 
fact that hemolysis occurred in only some of the studied 
dialysis sessions or not at all, suggests that hemolytic epi-
sodes were not related to single needle dialysis per se but 
to occasional factors. Not all single needle systems gave the 
same degree of hemolysis [61]. In a study with one of the 
earliest time regulated systems, no differences in free hemo-
globin in plasma were found before and after hemodialysis 
with single needle vs. double needle dialysis, in spite of the 
high number of alternating cycles per unit of time [1].
More recent studies report no clinical hemolysis [3, 6], no 
differences in LDH between single needle and double needle 
dialysis [59, 60], and no differences in serum haptoglobin 
[50]. However, as some of these studies were not undertaken 
with up to date equipment and all of them contained no com-
prehensive assessment of hemolysis markers, and in view of 
the toxicity and pro-inflammatory effect of free hemoglobin 
and heme [62, 63], this issue warrants further study.
Backfiltration
The push–pull of the classical single-needle systems result-
ing in alternating positive and negative pressures in the dia-
lyzer also induces an alternation of positive ultrafiltration 
and backfiltration. This might result in filter clogging but 
also in increased adequacy due to compulsory hemodiafil-
tration, and in spilling of dialysate content into the blood 
stream. The latter is however only a problem with contami-
nated and not with ultrapure dialysate.
Hemodiafiltration
It is generally not possible to combine single needle dialysis 
with hemodiafiltration with the current dialysis machines, 
which usually contain two pumps, whereby the second pump 
is used either for infusion of substitution fluid in hemodiafil-
tration or for the single needle approach. This does not pre-
clude that both strategies can be combined as it was possible 
to perform hemodiafiltration with the old pressure–pressure 
modulated devices [21]. Irrespective of this technical discus-
sion and the contradictory outcomes of controlled studies 
assessing survival outcomes with hemodiafiltration [64–67], 
one may wonder whether hemodiafiltration would be of 
much added value or even possible in the populations that 
according to this paper have most benefit from single needle 
dialysis, i.e. the elderly, those with cardio-vascular prob-
lems, patients with small and/or developing access systems, 
and home hemodialysis patients.
High venous return pressure
In view of the higher maximum blood flows than with two 
needle dialysis, return pressures in the access system might 
also be higher, which has the potential to damage the access 
system. This drawback might neutralize the positive poten-
tial of a more limited number of punctures (see above). How-
ever, the historic literature data we have available compar-
ing access outcomes with single needle versus two needle 
dialysis do not point into this direction [21, 22] (see above).
Table 4  Ranking and removal possibilities by dialysis of the uremic 
toxins with the highest level of toxicity
Solutes are ranked in order of evidence of their toxicity, based on 
[47]. Scoring system based on a maximum score of 4, correspond-
ing to 2 points for experimental evidence and 2 for clinical evidence. 
Only solutes with a score of 4 and 3 are listed and per score they are 
further ranked based on the number of organ systems that are toxi-
cally affected. Score: total evidence (maximum: 4)/total number of 
affected organ systems (maximum: 10) [47].Twelve toxins out of 69 
reviewed were considered highly toxic, of which 10 (83%) are dif-
ficult to remove, either because they are middle molecules (MM), 
protein bound (PB) or have complex kinetics (CK). Phosphate is not 
mentioned as the analysis [47] considered only anorganic toxins. 
However, phosphate could also be classified as toxic and with com-
plex kinetics [48, 49]
AGEs advanced glycation end products, ADMA asymmetric dimethyl 
arginine, TMAO trimethylamine-N-oxide
Molecule Easy to remove Dif-
ficult to 
remove
Reasons 
for difficult 
removal
Score
P-cresyl sulfate X PB, CK 4/7
β2-Microglobulin X MM, CK 4/6
ADMA X CK 4/5
Kynurenines X PB, CK 4/5
AGEs X MM, PB, CK 3/7
Indoxyl sulfate X PB, CK 3/6
Uric acid X 3/6
Ghrelin X MM, CK 3/5
Indole acetic 
acid
X PB, CK 3/5
Parathyroid 
hormone
X MM, CK 3/5
Phenylacetic acid X PB, CK 3/5
TMAO X 3/5
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Outcomes
There are virtually no data directly comparing outcomes 
with single needle dialysis to alternative strategies.
Before Kt/V was conceptualized, the time averaged urea 
concentration (TAC) over 1 week was used as a marker for 
dialysis adequacy. The relation of this parameter with out-
come had been assessed in the first randomized controlled 
trial (RCT) in dialysis, the USA National Collaborative 
Dialysis Study (NCDS), in which it was shown that the 
groups targeted to a lower TAC of urea had a better primary 
outcome which was hospitalization rate [68]. The study was 
insufficiently powered to find differences in mortality. Hos-
pitalization rate in the Ghent population on single needle 
dialysis, was similar as in the low TAC urea groups of the 
NCDS study [21]. Also TAC urea values were equivalent to 
the target values imposed by the NCDS in the low TAC 
urea groups with better outcomes [68]. Favorable outcomes 
with low TAC urea however necessitate a sufficient urea gen-
eration (equivalent to protein intake), as patients with low 
TAC urea with low protein intake had worse outcomes [68]. 
In the Ghent single needle population, urea generation was 
assessed by two independent methods, and again appeared 
conform the thresholds suggested by the NCDS [21, 68].
In a comparison of survival of patients in the Ghent single 
needle study versus contemporaneous data from the registry 
of the European Renal Association-European Dialysis and 
Transplant Association (ERA-EDTA) which supposedly 
contained a large majority of patients treated with double 
needle dialysis, outcomes of single needle dialysis were 
at least as good (and in fact better) [21]. However, even if 
the positive result was striking, one should be careful when 
comparing a single center with dedicated personnel to regis-
try data where all kinds of centers in various countries with 
different policies and philosophies are included. However, 
in the comparison with the NCDS discussed above [21, 68], 
the comparator was a population enrolled in an RCT, which 
are in general also patients subjected to careful follow-up.
Overall, these data suggests that if single needle dialy-
sis is carefully performed and not based on a selection of 
patients with insufficient access blood flows, outcomes can 
be similar to classical double needle dialysis.
Technical alternatives
Most modern hemodialysis machines contain an option 
allowing single needle dialysis. Such systems are usually 
conceived with pressure–pressure or pressure–time regu-
lated switch systems. Conceptually they are not different 
from those used several decades ago, only they are steered 
by software more than by human skills. Mostly the inherent 
software makes such systems easy to apply and removes the 
pressure upon the nurses to manually seek optimal adequacy, 
although this might come at the expense of somewhat lower 
dialyzer blood flows.
For several decades, the systems remained conceptually 
the same. Only recently, a modified alternative became avail-
able [3], using a switch system, arterial and venous expan-
sion chambers, automatic regulation of blood flow and one 
single pump. This allows to keep flow through the dialyzer 
constant and to avoid the clearance time loss of the tradi-
tional systems, with which flow has to build up from stand 
still to a maximum, each time an alternating pump starts 
turning. This technical modification allowed a gain in blood 
volume crossing the dialyzer by 35.8% and in dialyzer blood 
flow by 21.9% compared to the usual single needle sys-
tems [3]. As flow within the dialyzer is continuous instead 
of tidal, this could possibly impose less shear stress, and 
decrease the risk of hemolysis, thrombogenicity, and mem-
brane pore clogging by protein and cellular debris. Although 
the latter probably results in better removal capacity, data on 
removal of middle molecules and protein bound solutes with 
this novel system are unfortunately not available. Avoiding 
tidal flow may also prevent backfiltration.
Conclusions
Single needle hemodialysis has for several decades been 
neglected as an alternative hemodialysis strategy but is mak-
ing its reappearance, due to the recent introduction of alter-
native technical options next to a clinical necessity due to 
a gradual change in the epidemiological mix of the dialysis 
population. It offers a possibility for tailored, personalized 
dialysis and is especially suited for patients with small or 
maturing fistulae at the prerequisite that access flow is suffi-
cient, for those with pain at puncturing or fear for it, or as an 
option to avoid central vein catheter dialysis. Basically, how-
ever, this method is a valid option for every dialysis patient, 
as long as fistula flow is well enough, with as additional 
benefits less damage to the access system and better patient 
quality of life. Single needle dialysis seems especially suited 
for geriatric patients, in whom fistulae may be smaller and 
maturation slower than in the rest of the dialysis population 
and quality of life as a concern largely prevails on other 
aspects like hard outcomes. Another condition for which this 
technique seems specifically suited is home hemodialysis, 
where length of dialysis is less of a constraint, while easier 
and less strenuous access punctures may offer an extra ben-
efit for the patient or his/her partner.
Two potential drawbacks are that dialyzer blood flow 
cannot exceed a certain maximum and that Kt/V according 
to some may remain below threshold. Whereas the limited 
blood flow may also turn into an advantage as it optimally 
will result in a slower and more extended dialysis, Kt/V can 
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easily be corrected by slightly increasing dialysis length, if 
needed. The question should however be raised whether a 
non-evidenced outcome marker such as Kt/V [54] should 
prevail over the duty to provide personal comfort, access 
survival and regular dialysis delivery.
A consideration for the future may be that software and 
system design could be further modified, so as to reach by 
automated means what was possible at the time by man-
ual adjustment and expertise. In addition, more research is 
needed to analyze the currently available systems more in 
depth and to conform available knowledge with the current 
views on uremic toxicity and toxin removal, with a special 
need for direct data showing the impact on middle molecule 
and protein bound solute concentration. Other interesting 
research topics are the mechanistics of toxin removal by 
imposing different conditions of flow and stroke volume, 
which might emanate in a further finetuning of removal 
capacity.
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